Literature DB >> 2380964

Prolongation of the antiemetic action of P6 acupuncture by acupressure in patients having cancer chemotherapy.

J W Dundee1, J Yang.   

Abstract

Previous work from our department has shown that P6 acupuncture is an effective adjuvant to conventional antiemetic therapy for patients having cytotoxic drugs. However, its efficacy is limited to about 8 h. The current studies show that the application of an elasticized wrist band with a stud placed over the acupuncture point, and pressed regularly every 2 h, will prolong the antiemetic action for 24 h. This proved more effective in hospitalized patients (20/20) than in outpatients (15/20), presumably due to the encouragement given to regularly press the stud. Nausea and vomiting remain problems with cancer chemotherapy despite the use of antiemetics. Following encouraging results with P6 acupuncture (ACP) in postoperative sickness this has been shown to be effective in cancer chemotherapy in 105 patients who, despite the use of conventional antiemetics had been sick following the previous treatment. Electrical stimulation (10 Hz DC) of P6 point for 5 min before administration of the cytotoxic drugs was effective in preventing sickness in 66% and only 6% got no benefit. The ACP was given with the antiemetics which the patients had been receiving. Although there were no side effects with the ACP, the benefit only lasted 6-8 h. This was not important in hospitalized patients where the treatment could be repeated, but was a problem with outpatients. It has been shown that pressure on the P6 point (acupressure) has an antiemetic action. A commercially available elasticized band with a plastic stud (Sea Band) is an effective method of applying pressure to P6 point.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2380964      PMCID: PMC1292684          DOI: 10.1177/014107689008300608

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  8 in total

1.  Traditional Chinese acupuncture: a potentially useful antiemetic?

Authors:  J W Dundee; W N Chestnutt; R G Ghaly; A G Lynas
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-06

2.  Comparison of starting antiemetic treatment 24 hours before or concurrently with cytotoxic chemotherapy.

Authors:  C J Williams; C Davies; M Raval; J Middleton; J Luken; B Stone
Journal:  BMJ       Date:  1989-02-18

3.  Acupressure and postoperative vomiting.

Authors:  E N Fry
Journal:  Anaesthesia       Date:  1986-06       Impact factor: 6.955

4.  Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.

Authors:  M G Kris; R J Gralla; R A Clark; L B Tyson; J P O'Connell; M S Wertheim; D P Kelsen
Journal:  J Clin Oncol       Date:  1985-10       Impact factor: 44.544

5.  Nausea and vomiting as major complications of cancer chemotherapy.

Authors:  J Laszlo
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

6.  Clinical trials with antiemetic agents in cancer patients receiving chemotherapy.

Authors:  J S Penta; D S Poster; S Bruno; J S Macdonald
Journal:  J Clin Pharmacol       Date:  1981 Aug-Sep       Impact factor: 3.126

7.  Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.

Authors:  R J Gralla; L M Itri; S E Pisko; A E Squillante; D P Kelsen; D W Braun; L A Bordin; T J Braun; C W Young
Journal:  N Engl J Med       Date:  1981-10-15       Impact factor: 91.245

8.  Acupuncture prophylaxis of cancer chemotherapy-induced sickness.

Authors:  J W Dundee; R G Ghaly; K T Fitzpatrick; W P Abram; G A Lynch
Journal:  J R Soc Med       Date:  1989-05       Impact factor: 18.000

  8 in total
  13 in total

1.  Acupuncture as a complementary therapy in chemotherapy-induced nausea and vomiting.

Authors:  Ling Ma
Journal:  Proc (Bayl Univ Med Cent)       Date:  2009-04

Review 2.  Positive evidence for P6 acupuncture antiemesis.

Authors:  J W Dundee; C McMillan
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

3.  Effects of electroacupuncture on gastric migrating myoelectrical complex in dogs.

Authors:  L Qian; L J Peters; J D Chen
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

4.  Atropine-induced gastric dysrhythmia is not normalized by electroacupuncture.

Authors:  Chi-Sen Chang; Jen-Wei Chou; Chun-ying Wu; Yung-Hsien Chang; Chung-Wang Ko; Gran-Hum Chen
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

5.  The efficiency of the acupressure in prevention of the chemotherapy-induced nausea and vomiting.

Authors:  Aslı Genç; Gulbeyaz Can; Adnan Aydiner
Journal:  Support Care Cancer       Date:  2012-06-09       Impact factor: 3.603

6.  Randomized double-blind study of the Reliefband as an adjunct to standard antiemetics in patients receiving moderately-high to highly emetogenic chemotherapy.

Authors:  Imad Treish; Stacy Shord; John Valgus; Donald Harvey; Jessica Nagy; Jennifer Stegal; Celeste Lindley
Journal:  Support Care Cancer       Date:  2003-06-27       Impact factor: 3.603

7.  Acupuncture and acupressure for the prevention of chemotherapy-induced nausea--a randomised cross-over pilot study.

Authors:  Dieter Melchart; Angela Ihbe-Heffinger; Birgit Leps; Christoph von Schilling; Klaus Linde
Journal:  Support Care Cancer       Date:  2006-03-08       Impact factor: 3.603

8.  Non-invasive stimulation of the P6 (Neiguan) antiemetic acupuncture point in cancer chemotherapy.

Authors:  J W Dundee; J Yang; C McMillan
Journal:  J R Soc Med       Date:  1991-04       Impact factor: 18.000

9.  Pediatric acupuncture: a review of clinical research.

Authors:  Jeffrey I Gold; Colette D Nicolaou; Katharine A Belmont; Aaron R Katz; Daniel M Benaron; Wendy Yu
Journal:  Evid Based Complement Alternat Med       Date:  2008-01-10       Impact factor: 2.629

10.  Problems that patients feel are appropriate to discuss with their GPs.

Authors:  S J Spence
Journal:  J R Soc Med       Date:  1992-11       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.